Bioscience Inc News Today

PURE Bioscience, Inc. ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2024. Summary of Results ? Fiscal...

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On June 12, 2024, Yield10 Bioscience, Inc. filed a Certificate of Amendment to its Amended...

Population growth or size is an essential component of economic development. A robust and vibrant population allows countries to allocate more labor to industrial and other economic activities.

/PRNewswire/ -- SN Bioscience Co., Ltd. (CEO Park Young-hwan) announced on May 24 that European Medicines Agency(EMA) had granted an orphan drug designation...

INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 81,300 shares, an increase of 146.4% from the April 30th total of 33,000 shares. Approximately 2.2% of the company’s shares are short sold. […]

-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lympho

/PRNewswire/ -- The global assisted reproductive technology market size is estimated to grow by USD 8.23 billion from 2023-2027, according to Technavio. The...

Lendway Inc is expected to report for 1Q. NeuroMetrix Inc is expected to report for 1Q. Ocean Biomedical Inc is expected to report for 1Q. Petco Health & Wellness Co Inc is expected... -May 22, 2024 at 06:26 am EDT - MarketScreener

Thrive Bioscience announces Todd Lewis as Chief Commercial Officer ...

PURE Bioscience, Inc. , creator of the patented non-toxic silver dihydrogen citrate antimicrobial, today reported the appointment of Darin Zehr to its Board of Directors, effective as of May 1,...